Archives for Sensology and Neurootology in Science and Practice
Cochlear implantation has been performed for 16 years by investigators at Semmelweis University. During this period, different types of cochlear implants have been used and, in 30% of cases, hearing was observed to be restored in the nonimplanted ear.
Tinnitus as a symptom remains a serious multidisciplinary problem. Vertigo or dizziness is not noticed frequently in tinnitus patients, so vestibular function is not often studied.
Distortion product otoacoustic emission (DPOAE) is a widely used differential diagnostic method for diagnosing inner ear disorders. It provides us information on the condition of the outer hearing cells (OHCs).
This study reports 21 patients who suffered from vertigo and underwent a complete otorhinolaryngological evaluation and otoneurological tests to establish a peripheral labyrinthine disorder.
This study was conducted in an attempt to determine the efficacy of neurofeedback (NFB) in the treatment of patients suffering from vertigo or tinnitus. Results indicated that after NFB, power for delta and theta bands was reduced; however, an increase of power was noted for the alpha bands.
This preliminary report is an account of 21 consecutive patients who had tinnitus of the severe disabling type and were examined with quantitative electroencephalography (QEEG).
Temporomandibular joint dysfunction in whiplash injuries is usual. The author describes the mechanism of this joint dysfunction and the physiopathology of tinnitus and associated balance disorders.
A new version of craniocorpography (CCG), called computerized ultrasonographic CCG (Comp-USCCG), has been clinically applied for objective recording, documentation, and quantitative evaluation of abnormal psychomotor activity in psychiatric patients.
The application of slow vertex response audiometry (cortical evoked response audiometry), mainly in the diagnosis of pseudohypoacusis, is reported. This procedure is of interest in forensic audiology.
We carried out a retrospective survey of 25 years of clinical experience with the use of clonazepam as a vestibular and tinnitus suppressant in the pharmacological treatment of vestibular or cochleovestibular disorders due to different causes.
